Clinical Trials Directory

Trials / Unknown

UnknownNCT03396523

Losartan and Emotion Processing

Losartan Effects on the Extinction of Conditioned Fear in Humans

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
University of Electronic Science and Technology of China · Academic / Other
Sex
Male
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to investigate the effect of losartan (50mg, single dose) on the extinction of conditioned fear

Detailed description

In a double-blind, between-subject, placebo controlled design the effects of a single dose of losartan (50mg) on fear extinction in healthy male participants will be examined. Participants will initially undergo a Pavlovian fear conditioning procedure, followed by the administration of 50mg losartan or placebo. 90 minutes after treatment subjects will undergo the fear extinction procedure. Neural activity and psychophysiological indices of arousal will be assessed by the simultaneous acquisition of functional magnetic resonance imaging (fMRI) and skin conductance data.

Conditions

Interventions

TypeNameDescription
DRUGLosartanadministration of losartan (50 mg) (oral)
DRUGPlacebo Oral Tabletadministration of placebo (oral)

Timeline

Start date
2018-01-04
Primary completion
2018-10-31
Completion
2018-12-31
First posted
2018-01-11
Last updated
2018-06-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03396523. Inclusion in this directory is not an endorsement.